诊室宫腔镜联合蓝激光无麻醉取出宫内节育器-肌瘤复合体
一例56岁绝经7年、严重宫颈萎缩女性,宫内铜T形环留置超30年,超声见环被肌瘤样组织包裹形成约2.5×2.0×1.8 cm复合体,患者拒绝住院麻醉手术。采用18.5-Fr连续灌流宫腔镜、生理盐水100 mmHg持续循环、450 nm蓝激光30 W连续模式汽化肌瘤样组织后,以5-Fr抓钳将节育器与残余组织整块取出。手术成功,总操作时间36分钟,疼痛视觉模拟评分3/10,无术中并发症,术后少量阴道出血2天自止,1周随访超声宫腔正常无残留,病理证实良性平滑肌瘤。
要点
- 诊室无麻醉无扩宫宫腔镜联合蓝激光可取出宫内节育器-肌瘤复合体
- 适用于严重宫颈萎缩、高麻醉风险或拒绝住院的女性
- 总操作时间36分钟,疼痛评分3/10,无术中并发症
核心结论
- 诊室无麻醉无扩宫宫腔镜联合蓝激光取出宫内节育器-肌瘤复合体在严重宫颈萎缩绝经后女性中可行且安全。
- 该技术为高麻醉风险或偏好避免住院的女性提供以患者为中心的替代方案。
- 据作者所知,这是蓝激光用于此类困难条件下宫内节育器-肌瘤复合体的首例报告。
研究设计与样本
- 手术操作分步视频演示并附解说。
- 对象为1例56岁绝经7年女性(G2P2),T形铜质宫内节育器留置超过30年。
- 患者无绝经后出血或盆腔痛,查体示严重宫颈萎缩伴明显狭窄。
- 经阴道二维及三维超声示节育器被肌瘤样病变包裹,形成约2.5×2.0×1.8 cm的节育器-肌瘤复合体。
- 患者拒绝在麻醉下住院手术。
主要发现
- 手术成功完成,未转为全身麻醉或宫颈扩张。
- 总操作时间36分钟,患者耐受良好,报告轻度不适(视觉模拟评分疼痛评分3/10)。
- 无术中并发症,术后轻微阴道出血2天,自行缓解。
- 1周随访经阴道超声示宫腔正常,无残留节育器碎片或肌瘤组织。
- 残余组织碎片病理检查证实为良性平滑肌瘤。
关键数值与推荐
- 使用18.5-Fr连续灌流宫腔镜(5-Fr工作通道),不行麻醉或宫颈扩张。
- 以生理盐水为膨宫介质,压力100 mmHg,持续液体循环。
- 经工作通道引入450 nm蓝激光(30 W,连续模式)逐步汽化肌瘤样组织。
- 节育器完全暴露后,用5-Fr抓钳将节育器与残余肌瘤组织整块取出。
- 汽化后取残余组织碎片送病理检查。
临床怎么用
- 对严重宫颈萎缩、高麻醉风险或拒绝住院的绝经后女性,可考虑诊室无麻醉无扩宫宫腔镜联合蓝激光处理宫内节育器-肌瘤复合体。
- 术中采用18.5-Fr连续灌流宫腔镜、生理盐水100 mmHg持续循环及450 nm蓝激光30 W连续模式汽化组织。
- 节育器暴露后用5-Fr抓钳整块取出,残余组织送病理以确认良性性质。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the feasibility and safety of office-based, no-anesthesia, no-dilation hysteroscopic removal of an intrauterine device (IUD)-myoma complex using a blue laser in a postmenopausal woman with severe cervical atrophy. DESIGN: Step-by-step video demonstration of the surgical procedure with narrated explanation. SUBJECTS: A 56-year-old postmenopausal woman (G2P2, menopause for 7 years) with a T-shaped copper IUD indwelling for >30 years. She had no postmenopausal bleeding or pelvic pain. Examination revealed severe cervical atrophy with marked stenosis. Transvaginal ultrasound (both 2-dimensional and 3-dimentional) showed the IUD encased by a myoma-like lesion, forming an IUD-myoma complex measuring approximately 2.5 × 2.0 × 1.8 cm. The patient declined inpatient surgery under anesthesia. INTERVENTION: Office vaginoscopic hysteroscopy was performed without anesthesia or cervical dilation using an 18.5-Fr continuous-flow hysteroscope (5-Fr working channel). Normal saline was used as the distension medium at a pressure of 100 mm Hg with continuous fluid circulation. A 450-nm blue laser (30 W, continuous mode) was introduced through the working channel to vaporize the myoma-like tissue in a stepwise manner. Once the IUD was fully exposed, 5-Fr grasping forceps were used to remove the IUD together with the remaining myoma tissue en bloc. After vaporization, residual tissue fragments were retrieved for histopathological examination. MAIN OUTCOME MEASURES: Successful IUD removal, operative time, pain score (visual analogue scale, 0-10), intraoperative and postoperative complications, and follow-up ultrasound findings at 1 week. RESULTS: The procedure was successfully completed without conversion to general anesthesia or cervical dilation. Total operative time was 36 minutes. The patient tolerated the procedure well, reporting mild discomfort (visual analogue scale pain score, 3/10). No intraoperative complications occurred. The patient experienced slight vaginal bleeding for 2 days after operation, which resolved spontaneously. At the 1-week follow-up visit, transvaginal ultrasound revealed a normal uterine cavity with no residual IUD fragments or myoma tissue. Histopathological examination of the residual tissue fragments confirmed benign leiomyoma. CONCLUSION: Office-based, no-anesthesia, no-dilation hysteroscopic removal of an IUD-myoma complex using a blue laser is feasible and safe in a postmenopausal woman with severe cervical atrophy. This technique offers a patient-centered alternative for women at high anesthesia risk or who prefer to avoid hospital admission. To our knowledge, this is the first report of using a blue laser for an IUD-myoma complex under such challenging conditions.
引用
- Li C, Song F, Zhang L, et al. Office hysteroscopic removal of an intrauterine device-myoma complex using an 18.5-Fr hysteroscope and blue laser in a postmenopausal woman with cervical atrophy: a no-anesthesia approach. Fertil Steril. 2026. PMID: 42822686. doi:10.1016/j.fertnstert.2026.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。